COVID-19 and psoriasis: Should we fear for patients treated with biologics?

被引：33
作者：
Amerio, Paolo [1 ]
Prignano, Francesca [2 ]
Giuliani, Federica [1 ]
Gualdi, Giulio [1 ]
机构：
[1] Univ G DAnnunzio, Dept Med & Aging Sci, Dermatol Clin, Chieti, Italy
[2] Univ Florence, Dermatol Sect, Dept Hlth Sci, Florence, Italy
来源：
DERMATOLOGIC THERAPY | 2020年 / 33卷 / 04期
关键词：
biologics; COVID-19; psoriasis; SARS; therapy; CYTOKINE STORM; SARS;
D O I：
10.1111/dth.13434
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The new coronavirus pandemic poses question and challenges for dermatologists. One of question is if psoriasis patients treated with immunomodulating and immunosuppressive drugs have to discontinue their treatment in the midst of fears for the infection and its consequences. One of the challenges is how can we support our patients in this critical time. Previous coronaviruses outbreaks reports, current published evidences on pathogenesis and on clinical reports of COVID infection in immunosuppressed patients are used to make a scientifically based decision.
引用
收藏
页数：4
相关论文
共 30 条
  • [1] Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action"
    Abdelmaksoud, Ayman
    Goldust, Mohamad
    Vestita, Michelangelo
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [2] [Anonymous], 2020, CHINA CDC WEEKLY, V2, P113, DOI [DOI 10.46234/CCDCW2020.032, 10.46234/ccdcw2020.032]
  • [3] [Anonymous], 2020, DERMATOL THER, DOI DOI 10.1111/dth.13298
  • [4] [Anonymous], WORLD J PEDIATR 0319
  • [5] Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
    Arentz, Matt
    Yim, Eric
    Klaff, Lindy
    Lokhandwala, Sharukh
    Riedo, Francis X.
    Chong, Maria
    Lee, Melissa
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16): : 1612 - 1614
  • [6] Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
    Assiri, Abdullah
    Al-Tawfiq, Jaffar A.
    Al-Rabeeah, Abdullah A.
    Al-Rabiah, Fahad A.
    Al-Hajjar, Sami
    Al-Barrak, Ali
    Flemban, Hesham
    Al-Nassir, Wafa N.
    Balkhy, Hanan H.
    Al-Hakeem, Rafat F.
    Makhdoom, Hatem Q.
    Zumla, Alimuddin I.
    Memish, Ziad A.
    [J]. LANCET INFECTIOUS DISEASES, 2013, 13 (09) : 752 - 761
  • [7] Cascella M., 2020, FEATURES EVALUATION
  • [8] Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
    Channappanavar, Rudragouda
    Perlman, Stanley
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2017, 39 (05) : 529 - 539
  • [9] Middle East respiratory syndrome: pathogenesis and therapeutic developments
    Choudhry, Hani
    Bakhrebah, Muhammed A.
    Abdulaal, Wesam H.
    Zamzami, Mazin A.
    Baothman, Othman A.
    Hassan, Mohammed A.
    Zeyadi, Mustafa
    Helmi, Nawal
    Alzahrani, Faisal A.
    Ali, Ashraf
    Zakaria, Mohammad K.
    Kamal, Mohammad A.
    Warsi, Mohiuddin K.
    Ahmed, Firoz
    Rasool, Mahmood
    Jamal, Mohammad S.
    [J]. FUTURE VIROLOGY, 2019, 14 (04) : 237 - 246
  • [10] Expressive Suppression and Negative Affect, Pathways of Emotional Dysregulation in Psoriasis Patients
    Ciuluvica, Cristina
    Fulcheri, Mario
    Amerio, Paolo
    [J]. FRONTIERS IN PSYCHOLOGY, 2019, 10
123